To explore the role of UBE2M in breast cancer, we first determined its expression in two different subtypes of breast cancer cell lines (ER+: MCF7 and T47D cell lines; ER-: MDA-MB-231 and BT549 cell lines). Here, ESR1 is linked to breast carcinoma.